Back to Journals » Metalloproteinases In Medicine » Volume 1

Matrix metalloproteinases and their inhibitors in the gastrointestinal cancers: current knowledge and clinical potential

Authors Yeh Y, Sheu B

Received 30 April 2014

Accepted for publication 20 May 2014

Published 2 August 2014 Volume 2014:1 Pages 3—13

DOI https://doi.org/10.2147/MNM.S51000

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 2


Yi-Chun Yeh, Bor-Shyang Sheu

Department of Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan

Abstract: The matrix metalloproteinases (MMPs) family can degrade various components of the extracellular matrix and are implicated in a number of key normal processes. Aberrantly enhanced MMP proteolysis can lead to tumor growth, progression, and metastasis. Therefore, MMPs are considered important therapeutic and diagnostic targets for the treatment and detection of human cancers. This review summarizes the recent literature on MMPs and their inhibitors as diagnostic and prognostic predictors of gastrointestinal cancers, including esophageal squamous cell carcinoma, gastric cancer, colorectal cancer, hepatocellular carcinoma, and pancreatic cancer. Genetic and epigenetic alterations contribute to cancer progression and influence cancer susceptibility. Single nucleotide polymorphisms are the most common type of genetic variation, and can alter the expression and function of the encoded proteins. MicroRNAs are a family of small non-coding RNA molecules that function in post-transcriptional gene regulation. This review also focuses on the contribution of single nucleotide polymorphisms and microRNAs to the alteration of MMPs and their inhibitors.

Keywords: MMP, TIMP, gastrointestinal cancers, biomarker, SNP, miRNA

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]